CNBC 快讯 4月9日 14:09 催化剂密集型biotech板块的期权化趋势交易策略 A catalyst-rich biotech may be poised to resume its recovery. Use options to take advantage Regeneron's deep pipeline of potentially successful drugs helps to offset competitive risks in other areas. FG 100 读报告 →